Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Temozolomide × Clear all

Phase

Status

Sponsor Class

OTHER 74 INDUSTRY 25 NIH 12 NETWORK 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

stenoparib 1 sargramostim 1 poly ICLC 1 pembrolizumab 1 copanlisib 1 avelumab 1 Yoga 1 Temozolomide 1 PM 01183 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Ethiodized Oil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡